appropriate primers by the Biotechnology Center of the University of Illinois at UrbanaChampaign. The plasmid vector pRSFDuet-1 containing the nisA gene was digested with NdeI and XhoI and ligated with NdeI and XhoI digested PCR amplified nisB. The ligation and transformation of E. coli DH5α cells was carried out as described above. The colonies were analyzed for insert and plasmids were isolated from 5 colonies and sequenced.
Overexpression and purification of His 6 -tagged modified ProcA1.7G−1R, ProcA2.11G−1K, ProcA3.2TEV and ProcA3.3G−1K
E. coli BL21 (DE3) cells transformed with a pRSFDuet-1 vector carrying the genes for one of the ProcA peptides as well as procM were overexpressed in 2 L of LB medium containing 50 mg/L kanamycin at 37 °C until the O.D. 600nm reached 0.6−0.8. The culture was then induced with 0.1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) and shaken continually at 18 °C for an additional 20 h. The induced cells were harvested by centrifugation (11,900 × g for 20 min at 4 °C). The cell pellet was resuspended in 20 mL of LanA Start Buffer (20 mM NaH 2 PO 4 , pH 7.5 at 25 °C, 500 mM NaCl, 0.5 mM imidazole, 20% glycerol) and lysed by sonication (35% amplitude, 4.0 s pulse, 9.9 pause, 15 min). The sample was centrifuged (23,700×g for 40 min at 4 °C) and the supernatant was kept for further purification. The pellet was resuspended in 20 mL of LanA Start Buffer to obtain any soluble proteins remaining in the pellet. Insoluble materials were removed from the combined soluble fractions by centrifugation (11,900×g for 20 min at 4 °C), and the resulting sample was clarified using a 0.45 μm syringe filter (Corning). The His 6 -tagged peptides were then purified by immobilized metal affinity chromatography (IMAC) using a 5 mL HisTrap™ HP nickel affinity column (GE Healthcare Life Sciences). The filtered sample was applied to the column and the column was washed with 2 column volumes of LanA Buffer 1 (6 M guanidine hydrochloride, 20 mM NaH 2 PO 4 , pH 7.5 at 25 °C, 500 mM NaCl, 0.5 mM imidazole), followed by 2 ~ 3 column volumes of LanA Buffer 2 (4 M guanidine hydrochloride, 20 mM NaH 2 PO 4 , pH 7.5 at 25 °C, 300 mM NaCl, 30 mM imidazole), and then eluted with 3 column volumes of LanA Elution Buffer (4 M guanidine hydrochloride, 20 mM Tris, pH 7.5 at 25 °C, 100 mM NaCl, 1 M imidazole).
The elution fractions were purified by preparative reverse-phase high-performance liquid chromatography (RP-HPLC) using a Waters Delta-pak™ C4 15 µm 300 Å 25 × 100 mm PrepPac ® Cartridge. Solvents for the RP-HPLC were solvent A (0.1% TFA in water) and solvent B (0.086% TFA in 80% acetonitrile / 20% water). A gradient of 2-100% of solvent B was executed for over 45 min at a flow rate of 8 mL/min, and peptides were detected by absorbance at 220 nm. The fractions were analyzed by MALDI-ToF-MS. All the fractions containing the desired product were combined and the organic solvents were removed by rotary evaporation, followed by lyophilization overnight. The product was kept at −20 °C for short-term storage and −80 °C for long-term storage. The yields of the peptides were 22.6 mg, 62.0 mg, 57.9 mg, and 61.7 mg, respectively, for modified His 6 -ProcA1.7G−1R, His 6 -ProcA2.11G−1K, His 6 -ProcA3.2TEV, and His 6 -ProcA3.3G−1K from 2 L of cell culture.
Protease cleavage and tandem mass spectrometry analysis of prochlorosins
Modified ProcA mutants were cleaved by a commercial protease (trypsin for ProcA1.7G−1R, LysC for ProcA2.11G−1K and ProcA3.3G−1K, and TEV protease for ProcA3.2TEV) to remove the leader peptide. MALDI-TOF mass spectra of the modified peptides treated by proteases are shown in Figure 3 of the main text. The ring topology of lantipeptides can be deduced from their MS fragmentation pattern. 2 A sample of 5 μL of each protease cleavage reaction mixture was injected to a BEH C8 column (1.7 μm, 1.0 × 100 mm), and the fully modified product was purified by UPLC using a gradient of 3% mobile phase B (0.1% formic acid in methanol) to 97% mobile phase B in mobile phase A (0.1% formic acid in water) over 12 min. Mass spectra were acquired in ESI positive mode in the range of 50-2000 m/z. The capillary voltage was 3500 V, and the cone voltage was 40 V. The other parameters used were as follows: 120 °C source temperature; 300 °C desolvation temperature, 150 L/h cone gas flow, and 600 L/h desolvation gas flow. A transfer collision energy of 4 V was used for both MS and tandem MS, while the trap collision energy was set to 6 V for MS and a 20−55 V ramp for MSMS depending on the peptide. Glu-fibrinopeptide B (Sigma) was directly infused as the lock mass. The tandem mass spectra were processed with MaxEnt3 and analyzed by Protein/Peptide Editor in BioLynx 4.1. The software for analyzing both precursor-ion and fragment-ion mass was set to report any mass within 0.3 amu of the calculated expected values. Tandem mass spectra of the fully modified peptides treated by proteases (ProcA1.7G−1R core peptide with five dehydrations, ProcA2.11G−1K core peptide with five dehydrations, ProcA3.2TEV core peptide with three dehydrations, and ProcA3.3G−1K core peptide with three dehydrations) are shown in Figure S4 . Fragmentation patterns of these core peptides were consistent with the ring topology of prochlorosins previously obtained in vivo and in vitro.
2 Therefore, they are denoted as "Pcn in E. coli" (Pcn is short for prochlorosin, i.e. prochlorosin 1.7 is denoted as Pcn1.7).
HPLC purification of prochlorosins modified in E. coli
The protease cleavage reactions were quenched with 0.5% TFA, and the desired products purified by analytical RP-HPLC using a Vydac™ C18 5 µm 300 Å 4.6 i.d. × 250 mm column. Solvents for RP-HPLC were solvent A (0.1% TFA in water) and solvent B (0.086% TFA in 80% acetonitrile / 20% water). A gradient of 0.8-100% of solvent B was executed for over 50 min at a flow rate of 1 mL/min, and peptides were detected by absorbance at 220 nm. The fractions were tested by MALDI-ToF-MS for the desired peptides. All the fractions containing the desired fully modified product were combined and the solvents were removed by lyophilization overnight. The product was kept at −20 °C for short-term storage and −80 °C for long-term storage. The yields of the peptides with the purity shown in Figure S2 were 14% (0.16 mg), 19% (0.20 mg), 12% (0.17 mg), and 86% (1.09 mg) for Pcn1.7, Pcn2.11, Pcn3.2, and Pcn3.3, respectively, starting from 6.0 mg of modified precursor peptides before proteolysis. MALDI MS spectra of purified prochlorosins are shown in Figure S3 .
Incorporation of para-benzoyl phenylalanine (pBpa or B) in ProcA3. 2 The nucleotides encoding phenylalanine at position 26 of ProcA3.2TEV were substituted by the amber codon TAG. The mutant was generated by nested PCR using primers 5'-GCA GAC AAT ACA ATT GTC CCT TGC AGC TGC TAG CAC CAG TG S5 -3' (3.2_F26B_FP) and 5'-ATA ATT TAG CGG CCG CTC ACT GGT GCT AGC AG -3' (3.2_F26B_RP). The vector procA3.2TEV/procM/pRSFDuet-1 was used as the template.
E. coli BL21 (DE3) cells transformed with a pDule-Tyr vector (obtained from Professor Peter Schultz, the Scripps Research Institute) and a pRSFDuet-1 vector carrying both procA3.2TEV_F26B and procM were grown in 400 mL of glycerol minimal medium, supplemented with metals (for components, see Ref. 4 and 5), containing 50 mg/L kanamycin, 12.5 mg/L tetracycline and an 18-amino-acid solution (for components, see Ref. 4 and 5). The pDule-Tyr vector carrying an orthogonal aminoacyl tRNA synthetase-tRNA CUA pair can incorporate p-benzoyl-L-phenylalanine (pBpa) at the position encoded by the amber codon TAG. The culture was shaken at 37 °C until the O.D. 600nm reached 0.5, then pBpa dissolved in 1 M NaOH solution was added to the culture to obtain a final concentration of 1 mM pBpa. After shaken for 0.5 h, the culture was induced with 0.1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) and shaken continually at 18 °C for an additional 20 h. The induced cells were harvested by centrifugation (11,900×g for 20 min at 4 °C). The cell pellet was resuspended in 10 mL of LanA Start Buffer and lysed by sonication (35% amplitude, 4.0 s pulse, 9.9 pause, 15 min). The sample was centrifuged (23,700×g for 40 min at 4 °C) and the supernatant was kept for further purification. The pellet was resuspended in 10 mL of LanA Start Buffer again. The soluble portions after centrifugation (11,900×g for 20 min at 4 °C) were combined and clarified using 0.45 μm syringe filters (Corning), then purified by immobilized metal affinity chromatography (IMAC) using a 5 mL HisTrap™ HP nickel affinity column (GE Healthcare Life Sciences). The filtered sample was applied to the column and the column was washed with 2 column volumes of LanA Buffer 1, followed by 2 ~ 3 column volumes of LanA Buffer 2, and then eluted by 3 column volumes of LanA Elution Buffer. The elution fractions were desalted and purified by solid phase extraction (SPE) using a 3 mL Vydac® BioSelect™ reversed-phase C4 column. A step gradient of 2% solvent B (0.086% TFA in 80% acetonitrile / 20% water) in solvent A (0.1% TFA in water), 50% solvent B in solvent A, and 100% solvent B was applied for the purification. The fractions were tested by MALDI-ToF-MS for the desired peptides. The majority of ProcA3.2TEV with Phe26 substituted with pBpa eluted in fractions of 50% solvent B in solvent A.
An 18 µL sample of 50% solvent B eluted fraction was incubated with 0.03 U endoproteinase GluC in 50 mM tris buffer at room temperature for 6 h. The mixture was quenched with 0.5% (f.c.) TFA, zip-tipped and subjected to MALDI-ToF-MS (for the spectrum, see Figure 3d and Figure S5 ).
Overexpression and purification of HalA peptides
Electrocompetent E. coli BL21 (DE3) cells were transformed with the pDUET construct containing both the N-terminal hexa-histidine HalA-Xa fusion gene and the corresponding HalM gene. Cultures were inoculated from single colony transformants and grown overnight at 37 °C in LB broth supplemented with 50 mg/L kanamycin. The overnight culture was used to inoculate 2 L of LB broth, and cells were grown at 37 °C to O.D. 600 ≈0.6-0.8. Expression was induced by the addition of 0.5 mM IPTG, and the culture was incubated at 18 °C for 18 h. Cells were harvested by centrifugation at 6500×g for 20 min at 4 °C. The pellet (≈6 g) was resuspended in 30 mL of start buffer containing S6 20 mM sodium phosphate, pH 7.5, 20% glycerol, 500 mM NaCl, and 0.5 mM imidazole. The cell paste was subjected to sonication to lyse the cells. Cell debris was removed by centrifugation at 16,500×g for 20 min at 4 °C. The pellet was discarded and the supernatant containing the soluble peptide was passed through a 0.45 μm filter. The peptides were purified by immobilized metal affinity chromatography (IMAC) and reverse-phase high-performance liquid chromatography as described in previous work. The peptide sample was lyophilized and stored at −20 °C. Typical peptide yields from each construct were 1-2 mg of final, dried peptide per liter of overexpressed cells. The peptide product showed complete conversion as determined by MALDI-TOF and Tandem Mass Spectrometry ( Figure 3 of the main text).
Overexpression and purification of modified nisin
Chemically competent BL21(DE3) cells were co-transformed with pRSFDuet-1 containing the nisA and nisB genes and pACYCDuet-1 containing nisC. Overnight culture grown from a single colony transformant was used as inoculum to grow 1.5 L of terrific broth medium containing 50 mg/L kanamycin and 25 mg/L chloramphenicol at 37 °C until the OD600nm reached between 0.6 and 0.8. The incubation temperature was then changed to 18 °C and the culture was induced with 0.5 mM IPTG. The induced cells were shaken continually at 18 °C for an additional 15 h. The cells were harvested by centrifugation (11,900×g for 10 min, Beckman JLA-10.500 rotor). The cell pellet was resuspended in 45 mL of start buffer (20 mM Tris, pH 8.0, 500 mM NaCl, 10% glycerol, containing a protease inhibitor cocktail from Roche Applied Science) and lysed by MultiFlex C3 homogenizer (Avestin). The sample was centrifuged at 23,700×g for 30 min at 4 °C. The supernatant was loaded onto a HiTrap HP nickel affinity column (GE Healthcare) pre-equilibrated with start buffer. Following loading, the column was washed with wash buffer (start buffer + 30 mM imidazole). The peptide was eluted from the column using elution buffer (start buffer + 1 M imidazole). The pellet was homogenized using a sonicator (35 % amplitude, 4.4 s pulse, 9.9 s pause for total 20 min) in start buffer to remove any soluble proteins. The pellet from this step was resuspended in 30 mL of denaturing buffer (6 M guanidine hydrochloride, 20 mM NaH 2 PO 4 , 500 mM NaCL, pH 7.5). The insoluble portion was removed by centrifugation and supernatant was loaded onto a HiTrap HP nickel affinity column. The column was washed with denaturing buffer containing 30 mM imidazole and eluted with 15 mL denaturing buffer containing 1 M imidazole. Desalting of the eluent from both supernatant and pellet fractions was performed using preparative scale RP-HPLC using a Waters Delta-pak C4 15µm 300 Å 25X100 mm PrepPak Cartridge. A gradient of 2-100% of solvent B (0.086 % TFA in 80% acetonitrile/20% water) was used. Modified prenisin began to elute at 52% B. The fractions containing modified prenisin were lyophilized and analyzed by matrix-assisted laser desorption time of flight mass spectrometry (MALDI-TOF MS).
Factor Xa cleavage of modified HalA-Xa
Purified HalA-Xa peptides were dissolved (final concentration 1 mg mL -1 ) in Factor Xa assay buffer containing 50 mM Tris, 100 mM NaCl, 2 mM CaCl 2 , and 5 mM TCEP, pH 8.0. Factor Xa was added to a final concentration of 0.03 mg mL -1 . Cleavage reactions were incubated at 25 °C for 5 h and were quenched with 1% TFA. Reactions were lyophilized to dryness, resuspended in sterile water, and analyzed by MALDI-MS. Tandem mass spectrometry has confirmed the existence of overlapping rings at the C-terminal core peptide regions of Pcn2.11 and Pcn3.2 obtained both in vivo and in vitro. 2 However, how the two rings overlap is currently not known and one possible ring topology is shown. Fragmentation patterns of the four prochlorosins in ESI-MSMS. The N-terminal threonine of ProcA1.7G-1R core peptide is converted to dehydrobutyrine by ProcM. This dehydrobutyrine hydrolyzes to 2-oxobutyryl (Obr) group after trypsin cleavage at the cleavage site. Dehydrated serine residues (dehydroalanine, Dha) and threonine residues (dehydrobutyrine, Dhb) are highlighted in green. Other colors have the same meaning as in Figure S1 . Figure S5 . MALDI-MS spectrum of ProcA3.2TEV with Phe26 substituted by pBpa, modified by ProcM in E. coli and treated with GluC to remove the major part of the leader peptide. The remaining residues of the leader peptides after GluC cleavage are highlighted in yellow in the amino acid sequence shown in the figure. "B" representing the incorporation of pBpa is highlighted in grey. Cysteine residues are highlighted in red. Serine and threonine residues are highlighted in green. After modification by ProcM, these serine and threonine residues were dehydrated, which caused a mass shift in the MALDI-MS compared with the calculated mass of unmodified peptides with the same sequence (denoted as M in the figure) . A small amount of peptide resulting from translation termination at the amber stop codon is seen around 3100 Da. The ion with three dehydrations in the core peptide was the major product along with a minor amount of product with two dehydrations, as shown in the inset. Figure S6 . HPLC trace showing the purity of nisin produced in E. coli. The peak at 33 min is fully modified nisin. Figure S7 . ESI-MSMS analysis of commercial nisin (top) and in vivo produced and trypsin cleaved nisin (bottom). The b3 ion seen in both samples and the y30 ion seen in the bottom sample are uncommon for lanthionine rings but are consistently observed for intact nisin. Dha5 may be involved in this unusual cleavage of the A-ring in nisin.
Pcn3.2TEV_F26B NLYFQGGGCDGIRITDKQTVADNTIVPCSCBHQ

